Homepage
Latest Videos
Latest Videos
Brightcove Home Latest Listing
Breast Cancer
Breast Cancer
Brightcove Cards Listing
Prostate Cancer
Brightcove Cards Listing
Multiple Myeloma
Multiple Myeloma
Brightcove Cards Listing
Popular on MedEnrich
Popular in No name
Myelodysplastic Syndromes3m 18s
Anemia of MDS
Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
anemia
mds
transfusion dependence
1

Anemia of MDS
Myelodysplastic Syndromes8m 45s
Current Challenges in MDS Diagnosis and Consequences
Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
non invasive mds diagnosis
web based mds diagnosis tools
1

Current Challenges in MDS Diagnosis and Consequences
Breast Cancer14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
dose dense adjuvant chemotherapy
esmo
keynote -522
monarch -3 study
1

ESMO 2022 Breast Cancer Comprehensive Coverage
Multiple Myeloma10m 19s
CAR -T cells in Lymphoma
CAR-T cell therapies are approved for treatment of Diffuse Large B Cell Lymphoma (DLBCL) , Follicular Lymphoma & Mantle Cell Lymphoma.
car-t cell therapy
high risk lymphoma
1

CAR -T cells in Lymphoma
Oncology3m 36s
Tissue Agnostic Treatment options in Solid Tumors
Tissue-agnostic treatment based on shared genetic aberrations have provided a new direction in cancer treatment. Emerging clinical evidence indicates that many molecular aberrations can be common across tumor types with different site of origin.
personalized medicine
precision medicine
tissue agnostic treatment
1

Tissue Agnostic Treatment options in Solid Tumors
Breast Cancer12m 37s
Best practices for side effect management and patient monitoring with Palbociclib
Effective management of Palbociclib's side effects involves regular monitoring of blood counts to detect neutropenia, along with managing symptoms like fatigue, nausea, and infections.
side effects
patient monitoring
cdk4/6 inhibitors
palbociclib
1

Best practices for side effect management and...
Multiple Myeloma8m 2s
EHA 2022 Updates : Multiple Myeloma
EHA 2022 saw exciting progress particularly from the perspective of Bispecific Antibodies showing encouraging response rates in relapsed / refractory setting of Multiple Myeloma.
bcma targeting
bispecific antibodies
pneumocystis jirovecii pneumonia
1

EHA 2022 Updates : Multiple Myeloma
Multiple Myeloma9m 20s
Integrating Pomalidomide Based Regimens in Multiple Myeloma
Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
pomalidomide-dexamethasone
rrmm management
progression-free survival
combination therapies
1

Integrating Pomalidomide Based Regimens in Multiple...
Breast Cancer17m 33s
Outcome of Palbociclib based combination therapy vs endocrine monotherapy in real world setting
In real-world settings, Palbociclib-based combination therapy demonstrates improved progression-free survival and clinical benefit rates compared to endocrine monotherapy in HR+/HER2- advanced breast cancer.
palbociclib
endocrine monotherapy
hr+/her2- advanced breastcancer
palbociclib based combinations
1

Outcome of Palbociclib based combination therapy vs...
Myelodysplastic Syndromes17m 59s
Genomics of AML -Therapeutic and Prognostic Implications
~40% of AML patients have targetable mutations. Younger patients often have FLT3-ITD or FLT3- TKD mutation. Mutations IDH-1 , IDH-2 & t-53 mutations are more common in elderly patients.
idh 1& 2 mutations
flt3-tkd mutations
bcl2 inhibtors
genomics of aml
1

Genomics of AML -Therapeutic and Prognostic...
For Pharmacist
For Pharmacist
Brightcove Cards Listing
Webinars
Webinar Cards Listing
Upcoming Webinar
Upcoming Webinar
MedBytes
MedBytes
Medbytes Cards Listing
Notable KOLs
Discover Notable KOLs
BSc (Hons), BM (Hons), MRCP, PhD
M.D., MSCE
M.D.
M.D., MSC
M.D.
M.D.
M.D
MD, MBBCh, MRCP, FRCPath
M.D.
MD, PhD, Msc
MD, PhD
MD
MD, PhD
M.D., M.P.H.
Popular Topics
Popular Topics
Brightcove Most viewed videos Listing
Login
To get access to full MedEnrich experience, please Sign in
Don’t have an account? Register Now
Speakers